Cargando…
A Rare Presentation of Concomitant Lung Disease and Hepatitis After Rituximab Treatment: A Case Report
Rituximab (RTX) is a chimeric monoclonal antibody that is a standard component of treatment for all B-cell malignancies. The most common adverse events related to RTX are infusion-related reactions, such as fever, chills, urticaria, flushing, and headaches. However, RTX-induced lung disease (RTX-ILD...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257558/ https://www.ncbi.nlm.nih.gov/pubmed/37309343 http://dx.doi.org/10.7759/cureus.38910 |